Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.
Inflammatory bowel disease
Patient-focused registry
Work productivity
Journal
Journal of gastroenterology
ISSN: 1435-5922
Titre abrégé: J Gastroenterol
Pays: Japan
ID NLM: 9430794
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
20
12
2022
accepted:
01
06
2023
medline:
25
7
2023
pubmed:
23
6
2023
entrez:
23
6
2023
Statut:
ppublish
Résumé
The YOu and Ulcerative colitis: Registry and Social network (YOURS) is a large-scale, multicenter, patient-focused registry investigating the effects of lifestyle, psychological factors, and clinical practice patterns on patient-reported outcomes in patients with ulcerative colitis in Japan. In this initial cross-sectional baseline analysis, we comprehensively explored impacts of symptom severity or proctocolectomy on nine patient-reported outcomes. Patients receiving tertiary care at medical institutions were consecutively enrolled in the YOURS registry. The patients completed validated questionnaires on lifestyle, psychosocial factors, and disease-related symptoms. Severity of symptoms was classified with self-graded stool frequency and rectal bleeding scores (categories: remission, active disease [mild, moderate, severe]). The effects of symptom severity or proctocolectomy on nine scales for quality of life, fatigue, anxiety/depression, work productivity, and sleep were assessed by comparing standardized mean differences of the patient-reported outcome scores. Of the 1971 survey responses analyzed, 1346 (68.3%) patients were in remission, 583 (29.6%) had active disease, and 42 (2.1%) had undergone proctocolectomy. A linear relationship between increasing symptom severity and worsening quality of life, fatigue, anxiety, depression, and work productivity was observed. Patients with even mild symptoms had worse scores than patients in remission. Patients who had undergone proctocolectomy also had worse scores than patients in remission. Ulcerative colitis was associated with reduced mood, quality of life, fatigue, and work productivity even in patients with mild symptoms, suggesting that management of active ulcerative colitis may improve patient-reported outcomes irrespective of disease severity. (UMIN Clinical Trials Registry: UMIN000031995, https://www.umin.ac.jp/ctr/index-j.htm ).
Sections du résumé
BACKGROUND
The YOu and Ulcerative colitis: Registry and Social network (YOURS) is a large-scale, multicenter, patient-focused registry investigating the effects of lifestyle, psychological factors, and clinical practice patterns on patient-reported outcomes in patients with ulcerative colitis in Japan. In this initial cross-sectional baseline analysis, we comprehensively explored impacts of symptom severity or proctocolectomy on nine patient-reported outcomes.
METHODS
Patients receiving tertiary care at medical institutions were consecutively enrolled in the YOURS registry. The patients completed validated questionnaires on lifestyle, psychosocial factors, and disease-related symptoms. Severity of symptoms was classified with self-graded stool frequency and rectal bleeding scores (categories: remission, active disease [mild, moderate, severe]). The effects of symptom severity or proctocolectomy on nine scales for quality of life, fatigue, anxiety/depression, work productivity, and sleep were assessed by comparing standardized mean differences of the patient-reported outcome scores.
RESULTS
Of the 1971 survey responses analyzed, 1346 (68.3%) patients were in remission, 583 (29.6%) had active disease, and 42 (2.1%) had undergone proctocolectomy. A linear relationship between increasing symptom severity and worsening quality of life, fatigue, anxiety, depression, and work productivity was observed. Patients with even mild symptoms had worse scores than patients in remission. Patients who had undergone proctocolectomy also had worse scores than patients in remission.
CONCLUSIONS
Ulcerative colitis was associated with reduced mood, quality of life, fatigue, and work productivity even in patients with mild symptoms, suggesting that management of active ulcerative colitis may improve patient-reported outcomes irrespective of disease severity. (UMIN Clinical Trials Registry: UMIN000031995, https://www.umin.ac.jp/ctr/index-j.htm ).
Identifiants
pubmed: 37351647
doi: 10.1007/s00535-023-02005-7
pii: 10.1007/s00535-023-02005-7
pmc: PMC10366259
doi:
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
751-765Informations de copyright
© 2023. The Author(s).
Références
Gut. 2012 Feb;61(2):241-7
pubmed: 21646246
Inflamm Bowel Dis. 2018 Jun 8;24(7):1389-1400
pubmed: 29893949
Cochrane Database Syst Rev. 2020 Apr 16;4:CD012005
pubmed: 32297974
Am J Gastroenterol. 2015 Sep;110(9):1324-38
pubmed: 26303131
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
World J Gastroenterol. 2014 Jul 28;20(28):9458-67
pubmed: 25071340
Gastroenterol Hepatol. 2018 Oct;41(8):477-482
pubmed: 29937084
Am J Gastroenterol. 2000 Jan;95(1):145-51
pubmed: 10638574
Inflamm Bowel Dis. 2008 Dec;14(12):1660-6
pubmed: 18623174
PLoS One. 2017 Jul 27;12(7):e0181435
pubmed: 28749985
BMJ. 2016 Jul 01;354:i3319
pubmed: 27370543
Int J Nurs Stud. 2004 May;41(4):379-85
pubmed: 15050849
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
J Clin Nurs. 2005 Aug;14(7):798-804
pubmed: 16000093
Gastroenterol Res Pract. 2020 Apr 02;2020:2065383
pubmed: 32328091
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Inflamm Bowel Dis. 2015 May;21(5):1063-71
pubmed: 25723616
Aliment Pharmacol Ther. 2015 Nov;42(10):1200-10
pubmed: 26388424
Inflamm Bowel Dis. 2016 Oct;22(10):2474-81
pubmed: 27598738
Psychiatry Res. 2000 Dec 27;97(2-3):165-72
pubmed: 11166088
Inflamm Bowel Dis. 2017 Mar;23(3):333-340
pubmed: 28146002
Am J Gastroenterol. 1996 Aug;91(8):1571-8
pubmed: 8759664
Aliment Pharmacol Ther. 2011 Dec;34(11-12):1328-36
pubmed: 21999576
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Patient Prefer Adherence. 2018 Sep 18;12:1815-1823
pubmed: 30271125
J Crohns Colitis. 2020 Nov 7;14(11):1512-1523
pubmed: 32417910
J Crohns Colitis. 2017 Feb;11(2):165-174
pubmed: 27516406
J Med Econ. 2020 Oct;23(10):1061-1071
pubmed: 32713223
BMJ Open. 2019 Sep 8;9(9):e030134
pubmed: 31501121
Clin Gastroenterol Hepatol. 2017 Sep;15(9):1390-1396.e1
pubmed: 28110099
Am J Gastroenterol. 2015 Apr;110(4):484-8
pubmed: 25155226
J Crohns Colitis. 2014 Oct;8(10):1281-6
pubmed: 24662394
J Health Psychol. 2013 Apr;18(4):451-60
pubmed: 22689587
Nat Rev Dis Primers. 2020 Sep 10;6(1):74
pubmed: 32913180
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
Am J Gastroenterol. 2018 Jan;113(1):80-85
pubmed: 29134965
Colorectal Dis. 2021 Jan;23(1):18-33
pubmed: 32777171
Gut Liver. 2020 Jul 15;14(4):459-467
pubmed: 31533398
Am Rev Respir Dis. 1963 May;87:684-93
pubmed: 14015517
Am J Gastroenterol. 2004 Mar;99(3):457-61
pubmed: 15056085
J Clin Epidemiol. 2012 Oct;65(10):1107-16
pubmed: 22818947
Occup Med (Lond). 2014 Jul;64(5):393-4
pubmed: 25005549
Scand J Gastroenterol. 2019 Apr;54(4):465-470
pubmed: 31012338
BMC Gastroenterol. 2020 Jan 21;20(1):18
pubmed: 31964359
J Gastroenterol. 2018 Mar;53(3):305-353
pubmed: 29429045